TR-701

· Trius Therapeutics LLC (a subsidiary of Merck & Co., Inc.)

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for TR-701, covering 2014-08-07 to 2018-04-04. Get the full timeline:

Most recent: Clinical Trial Update: Food Effects of Single Oral Dose of 600mg TR-701 [Phase 1]